Summary
The study aimed to determine the most cost-effective treatment pathway for symptomatic Morton neuromas after failed conservative management. The researchers conducted an incremental cost-utility analysis, comparing a direct-to-surgery neurectomy strategy with three selective injection strategies.
These selective injection approaches involved ultrasound-guided injections of steroids, alcohol, or a combination of both before considering surgical neurectomy. The results indicated that the selective steroid/alcohol injection strategy was dominant, with an incremental cost-effectiveness ratio of $4401.61 per quality-adjusted life year (QALY) compared to no treatment.
The study concludes that a trial of ultrasound-guided injection therapies for Morton neuroma is a cost-effective strategy compared to proceeding directly to surgical neurectomy.
